United States · FDA National Drug Code directory
leader clearlax
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70000-0415_abf92abe-b5f3-4925-823f-5b28d0b15253
- Product NDC
- 70000-0415
- Form
- POWDER, FOR SOLUTION
- Composition / generic term
- Polyethylene Glycol 3350
- Labeler
- Cardinal Health 110, LLC. dba Leader
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20181227
- Source listing expiry
- 20261231
Source-listed ingredients
- POLYETHYLENE GLYCOL 3350 — 17 g/17g
These values do not establish equivalence or a dose recommendation.
Packages
- 119 g in 1 BOTTLE (70000-0415-1) · 70000-0415-1
- 238 g in 1 BOTTLE (70000-0415-2) · 70000-0415-2
- 510 g in 1 BOTTLE (70000-0415-3) · 70000-0415-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →